The correlation between insulin resistance and inflammation suggests that inflammation negatively impacts the PI-3 K/Akt signaling pathway responsible for NO production, leading to a decrease in NO bioavailability. This diminished availability of NO may undermine its substantial anti-inflammatory properties, consequently intensifying the development of inflammatory atherosclerotic lesions. The gene discussed is AKT1; the disease is Insulin resistance.